Notable Labs Ltd
NASDAQ:NTBL
Notable Labs Ltd
NASDAQ:NTBL
Price:
0.0255
USD
Market Cap:
$390k
Balance Sheet
Balance Sheet Decomposition
Notable Labs Ltd
Notable Labs Ltd
Balance Sheet Decomposition is not available for
Notable Labs Ltd
Notable Labs Ltd
Balance Sheet
Notable Labs Ltd
Notable Labs Ltd
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
37
|
7
|
12
|
7
|
29
|
9
|
13
|
22
|
18
|
12
|
|
| Cash |
37
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
12
|
7
|
29
|
9
|
13
|
22
|
18
|
12
|
|
| Short-Term Investments |
0
|
30
|
34
|
48
|
21
|
27
|
17
|
31
|
3
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
|
| Total Current Assets |
38
|
39
|
47
|
58
|
52
|
38
|
32
|
55
|
22
|
15
|
|
| PP&E Net |
0
|
0
|
1
|
7
|
9
|
10
|
9
|
9
|
7
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
7
|
0
|
10
|
9
|
9
|
7
|
2
|
|
| Accumulated Depreciation |
2
|
2
|
0
|
2
|
0
|
4
|
5
|
6
|
7
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Assets |
38
N/A
|
39
+3%
|
47
+20%
|
66
+39%
|
61
-8%
|
49
-19%
|
42
-15%
|
65
+55%
|
30
-54%
|
20
-34%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
2
|
3
|
3
|
1
|
3
|
2
|
4
|
1
|
2
|
|
| Accrued Liabilities |
2
|
2
|
0
|
3
|
0
|
5
|
5
|
5
|
6
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
2
|
1
|
3
|
0
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
3
|
4
|
5
|
8
|
5
|
9
|
7
|
10
|
7
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
2
|
2
|
4
|
3
|
3
|
0
|
1
|
|
| Total Liabilities |
3
N/A
|
4
+39%
|
5
+15%
|
10
+101%
|
8
-22%
|
13
+71%
|
11
-17%
|
12
+16%
|
7
-42%
|
4
-39%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
|
| Retained Earnings |
127
|
139
|
155
|
165
|
181
|
200
|
222
|
259
|
294
|
82
|
|
| Additional Paid In Capital |
162
|
174
|
197
|
221
|
234
|
236
|
253
|
309
|
317
|
97
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
35
N/A
|
35
0%
|
42
+21%
|
56
+32%
|
53
-5%
|
36
-32%
|
31
-14%
|
52
+69%
|
22
-57%
|
15
-33%
|
|
| Total Liabilities & Equity |
38
N/A
|
39
+3%
|
47
+20%
|
66
+39%
|
61
-8%
|
49
-19%
|
42
-15%
|
65
+55%
|
30
-54%
|
20
-34%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
9
|
|
Switch to:
Switch to:
See Also
Discover More
